Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single vs. Tandem Consolidation for High-Risk Neuroblastoma
NCT00567567Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Nov 2007
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of thiotepa, cyclophosphamide in neuroblastoma, sponsored by Children's Oncology Group. Started Nov 2007; status: completed.
02
Drugs
thiotepacyclophosphamide
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00567567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00567567.